Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 64

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: Results of a European multicenter, open-label study of patient preference

Ströberg, Peter, Murphy, Aileen, Costigan, Tim·2003·Clinical Therapeutics
DOI 10.1016/s0149-2918(03)80329-6
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0149-2918(03)80329-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 26

  1. Ignarro, 1990, Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle, Biochem Biophys Res Commun., 170, 843, 10.1016/0006-291X(90)92168-Y · DOI · Paper page
  2. Brock, 2002, Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses, J Urol., 168, 1332, 10.1016/S0022-5347(05)64442-4 · DOI · Paper page
  3. Saenz de Tejada, 2002, Effects of tadalafil on erectile dysfunction in men with diabetes, Diabetes Care, 25, 2159, 10.2337/diacare.25.12.2159 · DOI · Paper page
  4. Porst, 2003, Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial, Urology, 62, 121, 10.1016/S0090-4295(03)00359-5 · DOI · Paper page
  5. Hatzichristou, 2002, Sildenafil citrate: Lessons learned from 3 years of clinical experience, Int J Impot Res., 14, S43, 10.1038/sj.ijir.3900805 · DOI · Paper page
  6. Hellstrom, 2003, Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: Results of a randomized, double-blind, 26-week placebo-controlled pivotal trial, Urology, 61, 8, 10.1016/S0090-4295(03)00115-8 · DOI
  7. Goldstein, 2003, Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study, Diabetes Care, 26, 777, 10.2337/diacare.26.3.777 · DOI
  8. Carson, 2002, The efficacy of sildenafil citrate (Viagra) in clinical populations: An update, Urology, 60, 12, 10.1016/S0090-4295(02)01687-4 · DOI
  9. Moncada, 2003, Efficacy of sildenafil at 12 hours after its intake: Re-exploring the therapeutic window, Eur Urol Suppl, 2, 95, 10.1016/S1569-9056(03)80375-5 · DOI
  10. Hackett, 2002, What do patients expect from erectile dysfunction therapy?, Eur Urol Suppl, 1, 4, 10.1016/S1569-9056(02)00112-4 · DOI
  11. Boolell, 1996, Sildenafil, a novel effective oral therapy for male erectile dysfunction, Br J Urol., 78, 257, 10.1046/j.1464-410X.1996.10220.x · DOI
  12. Sadovsky, 2001, Three-year update of sildenafil citrate (Viagra) efficacy and safety, Int J Clin Pract., 55, 115, 10.1111/j.1742-1241.2001.tb10992.x · DOI
  13. Patterson, 2001, Dose-normalized pharmacokinetics of single-dose tadalafil (IC351) in healthy volunteers, Int J Impot Res., 13, S63
  14. Patterson, 2001, The effect of intrinsic and extrinsic factors on the pharmacokinetic properties of tadalafil (IC351), Int J Impot Res., S62
  15. Porst, 2002, Tadalafil allows men with erectile dysfunction to have successful intercourse up to 36 hours postdose, J Urol., 167, 177
  16. Jarow, 1996, Outcome analysis of goal directed therapy for impotence, J Urol., 155, 1609, 10.1016/S0022-5347(01)66142-1 · DOI
  17. Giuliano, 2000, Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: Results of a multicenter European study, J Urol., 164, 708, 10.1016/S0022-5347(05)67286-2 · DOI
  18. Chen, 2001, Sildenafil versus the vacuum erection device: Patient preference, J Urol., 166, 1779, 10.1016/S0022-5347(05)65674-1 · DOI
  19. Shabsigh, 2000, Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra), Urology, 55, 477, 10.1016/S0090-4295(99)00612-3 · DOI
  20. Souverein, 2002, Incidence and determinants of sildenafil (dis)continuation: The Dutch cohort of sildenafil users, Int J Impot Res., 14, 259, 10.1038/sj.ijir.3900883 · DOI
  21. Hatzichristou, 2000, Sildenafil versus intracavernous injection therapy: Efficacy and preference in patients on intracavernous injection for more than 1 year, J Urol., 164, 1197, 10.1016/S0022-5347(05)67140-6 · DOI
  22. Goldstein, 1998, Oral sildenafil in the treatment of erectile dysfunction, N Engl J Med., 339, 59, 10.1056/NEJM199807023390121 · DOI · Paper page
  23. Hellstrom, 2002, Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial, J Androl., 23, 763, 10.1002/j.1939-4640.2002.tb02332.x · DOI · Paper page
  24. Althof, 1999, EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction, Urology, 53, 793, 10.1016/S0090-4295(98)00582-2 · DOI · Paper page
  25. Pommerville, 2003, Erectile dysfunction: An overview, Can J Urol., 10, 2
  26. Rosen, 1997, The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0 · DOI · Paper page

Cited by

Metadata

Authors
Ströberg, P., Murphy, A., & Costigan, T.
Venue
Clinical Therapeutics
Publisher
Elsevier BV
Published
2003-11
Volume
25
Issue
11
Pages
2724-2737
ISSN
0149-2918
DOI
10.1016/s0149-2918(03)80329-6
Cited by
64
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.